Cargando…

Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis

Detalles Bibliográficos
Autores principales:	Baldi, Bruno Guedes, Pimenta, Suzana Pinheiro, de Melo Kawassaki, Alexandre, Bernardi, Fabíola Del Carlo, Dolhnikoff, Marisa, Carvalho, Carlos Roberto Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148482/ https://www.ncbi.nlm.nih.gov/pubmed/21876992 http://dx.doi.org/10.1590/S1807-59322011000700031

Ejemplares similares

Immunohistological features related to functional impairment in lymphangioleiomyomatosis
por: Nascimento, Ellen Caroline Toledo do, et al.
Publicado: (2018)

Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response ,
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2013)

Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2010)

Something not so new for lymphangioleiomyomatosis: is VEGF-D a glass half empty or half full?
por: Amaral, Alexandre Franco, et al.
Publicado: (2022)

The Expression of Water and Ion Channels in Diffuse Alveolar Damage Is Not Dependent on DAD Etiology
por: Pires-Neto, Ruy Camargo, et al.
Publicado: (2016)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
por: Freitas, Carolina Salim Gonçalves, et al.
Publicado: (2015)

Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease
por: Pereira, Daniel Antunes Silva, et al.
Publicado: (2013)

Lymphangioleiomyomatosis Presenting with Perirenal Hemorrhage
por: Dekeyzer, S., et al.
Publicado: (2015)

Desaturation-Distance Ratio During Submaximal and Maximal Exercise Tests and Its Association With Lung Function Parameters in Patients With Lymphangioleiomyomatosis
por: Queiroz, Douglas Silva, et al.
Publicado: (2021)

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
por: Baldi, Bruno Guedes, et al.
Publicado: (2022)

Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
por: Bernardi, Fabiola Del Carlo, et al.
Publicado: (2018)

Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2012)

Lymphadenopathy and fever in a chef during a stay in Europe
por: Kawano-Dourado, Letícia, et al.
Publicado: (2015)

Characterization and outcomes of pulmonary alveolar proteinosis in Brazil: a case series
por: de Athayde, Rodolfo Augusto Bacelar, et al.
Publicado: (2018)

Alveolar Hemorrhage
por: Popper, Helmut, et al.
Publicado: (2020)

Management of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2014)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
por: Freitas, Carolina S. G., et al.
Publicado: (2017)

Treatment of lymphangioleiomyomatosis and Camões
por: Rufino, Rogério
Publicado: (2015)

Methylprednisolone in the treatment of lymphangioleiomyomatosis
por: Dale, Ventour, et al.
Publicado: (2022)

Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)

Immunoglobulin G4-related systemic sclerosing disease in a patient with sclerosing cholangitis, inflammatory pseudotumors of the lung and multiple radiological patterns: a case report
por: Dias, Olívia Meira, et al.
Publicado: (2011)

Pulmonary lymphangioleiomyomatosis in a male.
por: Kang, H. W., et al.
Publicado: (1991)

Role of Prolactin Receptors in Lymphangioleiomyomatosis
por: Alkharusi, Amira, et al.
Publicado: (2016)

Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016)

Recent advances in the management of lymphangioleiomyomatosis
por: Xu, Kai-Feng, et al.
Publicado: (2018)

Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax
por: Odak, Mihir, et al.
Publicado: (2020)

Lymphangioleiomyomatosis: a clinical review
por: O'Mahony, Anne M., et al.
Publicado: (2020)

Lymphangioleiomyomatosis: Searching for potential biomarkers
por: Revilla-López, Eva, et al.
Publicado: (2023)

Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification
por: Baldi, Bruno Guedes, et al.
Publicado: (2021)

COVID-19 and pulmonary alveolar proteinosis: an unusual combination
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022)

Alveolar Hemorrhage
por: White, W. A.
Publicado: (1899)

Alveolar Hemorrhage
por: Wells, Jason, et al.
Publicado: (2014)

Alveolar Hemorrhage
por: Watt, Geo.
Publicado: (1859)

Computed tomographic findings of tuberous sclerosis with pulmonary lymphangioleiomyomatosis and renal angiomyolipomas: a case report
por: Vianna, Flavia Gavinho, et al.
Publicado: (2009)

Lymphangioleiomyomatosis With Atypical Presentation Following Pneumothorax: A Case Report
por: Rodrigues, Rita Q, et al.
Publicado: (2023)

Lymphangioleiomyomatosis: differential diagnosis and optimal management
por: Xu, Kai-Feng, et al.
Publicado: (2014)

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2015)

Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis
por: Ellender, Claire M, et al.
Publicado: (2015)

Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma
por: Sun, Xuefeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ln3vqdqv8lhkkbi8v2fb1dmg4q